Analisis Trend Peresepan Golongan Antipsikotika Tipikal dan Atipikal di Tiga Puskesmas di Kota Banjarmasin Periode 2019-2021
Trend Analysis of Prescribing Typical and Atypical Antipsychotics at Three Health Centers in Banjarmasin City for the 2019-2021 Period
DOI:
https://doi.org/10.25026/jsk.v4i4.1269Keywords:
antipsychotic, schizophrenia, pattern of use, primary care health centerAbstract
Antipsychotics are the first-line treatment option for schizophrenia, with the goal of reducing symptoms and preventing relapse. The study aimed to identify and analyze changes in the pattern of use of antipsychotics in prescribing schizophrenia patients based on the category of drug name, class, and dosage form from 2019 to 2021 at 3 primary health care centers in Banjarmasin. The study was designed as a descriptive study, with data collected retrospectively and using a purposive sampling technique based on inclusion and exclusion criteria. A total of 154 samples were analyzed. The results showed a change in the frequency of use of antipsychotics based on the category of drug names, i.e., haloperidol, chlorpromazine, trifluperazine, clozapine, and risperidone; data on the use of the typical antipsychotic group continued to increase compared to the atypical group; and there was no change in the form of prescribing antipsychotics in tablet form. As a result, it was concluded that there is a shift in the use of antipsychotics through prescribing in schizophrenia patients, as evidenced by a change in the percentage of use of both drug items and antipsychotic groups at the 3 primary care health centers from 2019 to 2021.
References
S. Rasool, M. Z. Zafar, Z. Ali, and A. Erum. 2018. Schizophrenia?: An overview. Clin. Pr., vol. 15, no. 5, pp. 847–851. doi: 10.4172/clinical-practice.1000417.
WHO. 2019. Schizophrenia. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/schizophrenia
K, Kochi., et al. 2017. Trends in antipsychotic prescriptions for Japanese outpatients during 2006–2012: a descriptive epidemiological study. Pharmacoepidemiol. Drug Saf., vol. 26, pp. 642–656, 2017, doi: 10.1002/pds.4187.
Yulianty, M. D., N. Cahaya & V. M. Srikartika. 2017. Studi Penggunaan Antipsikotik dan Efek Studi Penggunaan Antipsikotik dan Efek Samping pada Pasien Skizofrenia di Rumah Sakit Jiwa Sambang Lihum Kalimantan Selatan. Jurnal Sains Farmasi & Klinis. 3 (2): 153-164.
Jarut, Y. M., Fatimawali & W. I. Wiyono. 2013. Tinjauan Penggunaan Antipsikotik Pada Pengobatan Skizofrenia Di Rumah Sakit Prof. Dr. V. L. Ratumbuysang Manado Periode Januari 2013- Maret 2013. Jurnal Ilmiah Farmasi. 2 (2): 54–57.
Roberts, R., A. Neasham., C. Lambrinudi & A. Khan. 2018. A Quantitative Analysis of Antipsychotic Prescribing Trends for the Treatment of Schizophrenia in England and Wales. Journal of the Royal Society of Medicine. 9 (4): 1–7.
Roh, D., J. Chang., S. Yoon & C. Kim. 2015. Antipsychotic prescribing patterns in Antipsychotic Prescribing Patterns in First-episode First-episode Schizophrenia: A Five-year Comparison. Clinical Psychopharmacology and Neuroscience. 13 (3): 275–282.
Faqih, M., Hendra & D. Hartanto. 2021. Evaluasi Pengobatan Antipsikotik pada Pasien Skizofrenia di Rumah Sakit Jiwa Sambang Lihum. Journal of Current Pharmaceutical Sciences. 5 (1): 439–446.
Taipale, H., Puranen. A., M. Ellenor., J. Tiihonen., A. Tanskanen., S. M., Cervenka & Lähteenvuo, M. 2021. Antipsychotic Use Among Persons with Schizophrenia in Sweden and Finland, Trends and Differences. Nordic Journal of Psychiatry. 75 (5): 315–322.
Kemenkes RI. 2021. Pedoman Pelayanan Kefarmasian pada Pasien Gangguan Jiwa. Kementerian Kesehatan Republik Indonesia, Jakarta.
Maslim, R. 2013. Diagnosis Gangguan Jiwa Rujukan Ringkas dari PPDGJ - III. PT Nuh Jaya, Jakarta.
Tardy, M., Huhn, M., Kissling, W., Engel, R. R., & Leucht, S. 2014. Haloperidol Versus Low Potency First Generation Antipsychotic Drugs for Schizophrenia. Cochrane Database of Systematic Reviews. 7: 1-87.
Tjay dan Raharja. 2007. Obat-Obat-Penting. PT Elex Media Komputindo Gramedia, Jakarta., p. 915.
Kemenkes RI. 2014. Panduan Praktik Klinis Bagi Dokter di Fasilitas Pelayanan Primer Edisi II,” Menteri Kesehaan Republik Indonesia. p. 150.
M. A. & W. I. H. Hendra, G. A.2020. Analisis Hubungan Kualitas Hidup Terhadap Penggunaan Kombinasi Obat Antipsikotik Pada Pasien Skizofrenia. J. Kesehat. dr. Soebandi, vol. 8, pp. 128–134, 2020, doi: 10.36858/jkds.v8i2.229.
S. S. & V. F. Koch, K., K. Haynes., E. Adams. 2014. Trifluoperazine Versus Placebo for Schizophrenia. doi: 10.1002/14651858.CD010226.pub2.
S. M. Stahl. 2010. Stahl’ s Essential Psychopharmacology Neuroscientific Basis and Practical Application, vol. 8.
Ratnasari, I. D. 2018. Analisis Drug Related Problems Penggunaan Antipsikotik Pada Penderita Schizophrenia Dewasa Di Rumah Sakit Jiwa X Surabaya. Jurnal Ilmiah Mahasiswa Universitas Surabaya. 7 (1): 721–735.
H. & D. H. Faqih, M. 2021. Evaluasi Pengobatan Antipsikotik pada Pasien Skizofrenia di Rumah Sakit Jiwa Sambang Lihum. J. Curr. Pharm. Sci., vol. 5, pp. 439–446.
Patel, K. R., J. Cherian., K. Gohil & D. Atkinson. 2014. Schizophrenia: Overview and Treatment Options. Pharm Ther. 39 (9): 638–645.
H. Y. Meltzer, “The role of clozapine in treatment-resistant schizophrenia,” Adv Biol Psychiatry, vol. 26, no. 3, pp. 114–128, 2010, doi: 10.1001/jamapsychiatry.2015.2966.
Himei, A & T. Okamura. 2005. Evaluation of the Clinical Efficacy of Risperidone for Untreated and Treated Cases of Schizophrenia from Various Aspects. Psychiatry and Clinical Neurosciences. 59: 556–562.
Indriani, A., W. Ardinngrum & Y. Febrianti. 2019. Studi Penggunaan Kombinasi Antipsikotik pada Pasien Skizofrenia di Rumah Sakit Yogyakarta. Majalah Farmasetika. 4 (1): 201–211.
Menteri Kesehatan Republik Indonesia. 2017. Keputusan Menteri Kesehatan Republik Indonesia Nomor 659 Tahun 2017 Tentang Formularium Nasional.
Christiani, M., Sudarso & D. Setiawan. 2010. Keamanan Obat Anti Psikotik bagi Penderita Skizofrenia di Rumah Sakit Umum Daerah Banyumas Tahun 2009. Pharmacy. 7 (1): 8–23.
Julaeha., V. D. Ananda & D. A. Pradana . 2016. Gambaran Efek Samping Antipsikotik pada Pasien Skizofrenia pada Bangsal Rawat Inap di Rs. Grhasia Yogyakarta. Farmasains. 3 (1): 35–41.
M. A. Dhale, Pola Pengobatan Penderita Skizofrenia Tipe Tak Terinci di Instalasi Rawat Inap Rumah Sakit Jiwa Daerah Provinsi DIY Periode Januari-Juni 2000. 2022.
Mahalli, A. A. El. 2012. WHO / INRUD Drug Prescribing Indicators at Primary Health Care Centres in Eastern Province, Saudi Arabia. Eastern Mediterranean Health Journal. 18 (11): 1091–1096.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Jurnal Sains dan Kesehatan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
